Kanda, T., Yasui, S., Nakamura, M., Suzuki, E., Arai, M., Ooka, Y., . . . Yokosuka, O. (2017). Real-World Experiences with the Combination Treatment of Ledipasvir plus Sofosbuvir for 12 Weeks in HCV Genotype 1-Infected Japanese Patients: Achievement of a Sustained Virological Response in Previous Users of Peginterferon plus Ribavirin with HCV NS3/4A Inhibitors. Int J Mol Sci.
Dyfyniad Arddull ChicagoKanda, Tatsuo, et al. "Real-World Experiences With the Combination Treatment of Ledipasvir Plus Sofosbuvir for 12 Weeks in HCV Genotype 1-Infected Japanese Patients: Achievement of a Sustained Virological Response in Previous Users of Peginterferon Plus Ribavirin With HCV NS3/4A Inhibitors." Int J Mol Sci 2017.
Dyfyniad MLAKanda, Tatsuo, et al. "Real-World Experiences With the Combination Treatment of Ledipasvir Plus Sofosbuvir for 12 Weeks in HCV Genotype 1-Infected Japanese Patients: Achievement of a Sustained Virological Response in Previous Users of Peginterferon Plus Ribavirin With HCV NS3/4A Inhibitors." Int J Mol Sci 2017.